The NBA is extending its policy of not randomly drug testing players for marijuana for the 2020-2021 season amid the coronavirus pandemic. And insiders suspect that the relaxed cannabis rules will continue indefinitely.

Marijuana testing was first suspended earlier this year as players finished out their season in the so-called “bubble” arena in Orlando. But as first reported by freelance journalist Ben Dowsett on Thursday, the league and the players’ union have agreed to maintain that policy, at least for the next season.

“Due to the unusual circumstances in conjunction with the pandemic, we have agreed with the NBPA to suspend random testing for marijuana for the 2020-21 season and focus our random testing program on performance-enhancing products and drugs of abuse,” an NBA spokesperson said.

But pressure has been mounting on the league to end testing for marijuana permanently.

Michele Roberts, the head of the National Basketball Players Association (NBPA) who also joined the board of the major cannabis company Cresco Labs this year, predicted in a recent interview that the formal change could come as early as “next season.”

“We’re not going to expose our players to unnecessary risks,” she told Dowsett in a piece for GQ. “And it is not necessary to know whether our players are positive for marijuana.”

NBA Commissioner Adam Silver hasn’t ruled out adopting new policies on marijuana testing, but he’s said that the league needs to proceed carefully so as not to send a wrong message to young people. He’s also voiced support for exploring the medical potential of cannabis.

“At the end of the day, I think we all agree that, whether or not marijuana is a legal substance, just like with alcohol, you still have to teach young people how to use a substance like that appropriately and responsibly and so it doesn’t overwhelm your life,” he said. “So, it’s a complicated issue.”

While NBA won’t be subjecting players to random drug testing for THC, they will continue to test “for cause” cases where players have histories of substance use, for example.

If NBA does ultimately end marijuana testing, it would be another example of evolving drug policies within national sports leagues. Earlier this year, the MLB announced that players would not longer be tested for cannabis, though they’re barred from being sponsored by marijuana companies.

The NFL also made the decision to end suspensions for positive drug tests as well as limiting the testing window.

This article has been republished from Marijuana Moment under a content-sharing agreement. Read the original article here.

Featured image by Gina Coleman/Weedmaps

The post NBA players won't be tested for marijuana next year as league weighs permanent change appeared first on Weedmaps News.

Read More

Well, the holidays are here — and so is the second (or third?) wave of Covid. Like all things 2020, it’s going to be a strange season to navigate, with varying degrees of lockdown and travel advisories marring any plans you may have had.

And while everything about the holiday season doesn’t sparkle like tinsel, the dichotomy of familial obligations and nostalgic warmth makes this season what it is. This year, however, we’ll have to manifest that fuzzy feeling on our own. 

The key to this pandemic holiday is finding ways to foster that familial closeness despite physical distance. While there are a few ways to do this, like compulsive baking and blasting Mariah Carey, there’s no better way to spread cheer from afar than gifting edible cannabis.

While edibles tend to get a bad rep because of new users’ tendencies to over-medicate, they can actually be a fantastic way to break down the stigma surrounding cannabis. With developments like microdosing, nano THC (nano edibles hit in 15 minutes as opposed to 1 to 2 hours), and a massive expansion in the luxury edibles market, the genre has come a long way since the days of questionable dosages and pot brownie freak outs

Whether you’re shopping for a canna-curious relative, your stoner friend, or  yourself, we’ve compiled a comprehensive list of some of the best, most unique, and future-forward edibles on the market. 

Pop-Up Potcorn 

Pop-Up PotcornPop-Up Potcorn

The savory treat we’ve all been waiting for, Pop-Up Potcorn features varieties of healthy popcorn infused with live resin. 

The brainchild of workers on a California cannabis farm, flavors like Jalapeno Cheddar, Movie Theater Butter and Sea Salt are available in 10 milligram THC personal bags, 100 milligram party bags, and microwavable options. Available in California



Sonder Space Crystals

The wife and wife team behind Sonder, a beautifully designed vape brand who grows their own weed at their Emerald Triangle farm, have blessed the world with the first weed pop rocks: Space Crystals. 

With their stunning design, fanciful flavors and 10 milligrams of nano-emulsified THC that hits almost immediately, this effervescent gift will make the season snap, crackle and pop. Available in California


Rose x Gossamer Turkish Delights

Rose x Gossamer Turkish DelightsRose Delights

One of the chicest edible brands in existence, Rose Delights, has teamed up with Gossamer, one of the chicest cannabis publications in existence, to bring us the apex of giftable weed: the Rose x Gossamer Turkish Delights. 

Created by Chef Tara Thomas, these divine Turkish Delights feature locally sourced ingredients like dry-farmed tomatoes and Sweet Crimson watermelon infused with Magic Melon flower rosin. Available in California



Platinum Baked Apple Gummies

Conjure your grandma’s homemade apple pie with Platinum Vape‘s Baked Apple Gummies. Sweet, spiced, and 10 milligrams each, these gummy coins bring the comforts of home — and the high. Available in California and Oklahoma.


Papa & Barkley Releaf Chocolate Bars

Papa & Barkley Releaf Chocolate BarsPapa & Barkley

Known for their popular topicals, Papa & Barkley has upped the ante with their new line of uber relaxing chocolate bars. Silky and decadent with a high to match, Releaf Chocolates are available in Milk Chocolate or Dark Chocolate and Sea Salt, and are infused with 5 milligrams of whole plant rosin per serving. Available in California.



Mellow Ice Cream 

One of the only good things to happen in 2020, Mellow Ice Cream is a new California brand featuring THC and CBD infused ice creams. These masterfully formulated flavors not only taste like your childhood favorites, but will make you feel like a kid again, too. Available in California.

Citrus Spice Deli Nickels Gummy Rounds

Citrus Spice DELI Nickels Gummy RoundsDELI

This seasonal flavor of 5 milligram THC gummies from Caliva features a tart, enticing burst of blood orange and a sativa-leaning high that leaves you, in a word, chipper. 

10/10 would recommend for spreading holiday cheer — remotely, of course. Available in California.



La Familia Churro Crispies

Churro Crispies are a unique and fabulous treat from the first Mexican-owned California edibles brand, La Familia. At 10 milligrams each, these churro-flavored rice crispy balls are the closest thing you can get to a perfectly executed street churro, if said churro also got you perfectly stoned. Available in California


Hervé Macarons 

Hervé Macarons

A defining new brand in the luxury edibles market, Nevada’s Hervé specializes in 10 milligram French macarons that rival even the fanciest bakery. 

Beautifully executed with a social high, these are a perfect gift for the canna-curious — and highly refined — human in your life. Available in Nevada


Lost Farm Single Strain Gummies 

A new brand from Kiva, Lost Farm features strain-specific live resin gummies. Delicious, potent, and fun as fuck, these 10 milligram gummies will turn even the bleakest holiday into the kind of party we used to take for granted. Available in California


1906 New Highs LOVE Chocolates

1906 New Highs LOVE Chocolates1906 New Highs

If you’re lucky enough to be locked down with a significant other this winter, look no further than 1906 New Highs‘ LOVE chocolates to make the season bright. Packed with 5 milligrams of Blue Dream cannabis and arousing botanicals, these can steam up even the coldest nights. Available in Colorado and Oklahoma.



Madame Munchie Macarons

With their potent dosage of 40 milligrams of THC, fun seasonal flavors, and epic brand story, Madame Munchie‘s French macarons exist on the super stoner end of the infused macaron spectrum. 

Not only does this woman and queer-owned brand grow all their own weed, but their all-women team works tirelessly to make everything by hand. A perfect present for your favorite super toker from a DIY brand you can feel good supporting. Available in California


Lifted Made Delta-8 THC gummies

Lifted Made Delta-8 THC gummiesUrb

Urb’s Delta-8 Gummies by Lifted Made are indicative of a growing trend in cannabis where cannabinoids other than CBD and THC are featured in products. While similar to THC — technically called Delta-9 THC — Delta-8 THC is lauded for its clear, focused high, free from the anxiety that often plagues typical THC. 

Great for handling whatever this season may bring, these gummies have a unique trip that is alert, productive, and above all else, merry! Available in California.


Featured image by Gina Coleman/Weedmaps

The post 13 weed-infused gifts for the edibles lover appeared first on Weedmaps News.

Read More

The U.S. House of Representatives approved a bill to federally legalize marijuana in a historic vote on Friday.

It’s the day that cannabis reform advocates have been building toward for years—a full floor vote to end prohibition in a chamber of Congress.

Prior to the bill’s approval in a 228 to 164 vote, Republican lawmakers spent days criticizing their Democratic counterparts for even bringing the legislation to the floor.

While the vote was mostly along party lines, five Republicans supported the reform and six Democrats opposed it.

Under the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act, cannabis would be federally descheduled and those with prior convictions would have their records expunged. The descheduling provisions would be retroactive, too.

Despite the unprecedented House victory for reformers, few believe the legislation stands a chance in the Republican-controlled Senate, at least before the end of the current Congress early next month. Vice President-elect Kamala Harris (D-CA) is the lead sponsor of the Senate companion version of the bill.

Ahead of the bill’s passage, debate on the floor largely consisted of Democrats making the case that the reform will help to right the wrongs of the racist war on drugs, and Republicans arguing that legalization would cause harms to children and public safety and that now is not the right time to consider the issue in any case.

“Across this nation, thousands of men and women have suffered needlessly from the federal criminalization of marijuana, particularly in communities of color and have borne the burden of collateral consequences for those ensnared in criminal legal systems that have damaged our society across generations,” Rep. Sheila Jackson Lee (D-TX) said in her opening remarks. “This is unacceptable and we must change our laws. It is time for Congress to catch up with the reforms that states are enacting.”

Rep. Matt Gaetz (R-FL), the sole GOP cosponsor of the legislation, said that while he feels the bill is “flawed,” he is voting for it “because the federal government has lied to the people of this country about marijuana for a generation.

“We have seen a generation, particularly of black and brown youth, locked up for offenses that not should have not resulted in any incarceration whatsoever,” he said.

The fourth-ranking Democrat in the House, Rep. Hakeem Jeffries (D-NY), said cannabis criminalization represents “a stain on our democracy,” emphasizing ongoing racial disparities in enforcement despite the fact that black and white people use marijuana at roughly the same rates.

Congressional Cannabis Caucus Co-chair Barbara Lee (D-CA) said the MORE Act “is an important racial justice measure” and “the product of years of work by so many activists and advocates and young people—and it’s long overdue.”

“It’s time to end these unjust laws which has shattered the lives of so many young people of color,” the congresswoman, who presided over the chamber during the final vote, said.

Rep. Earl Blumenauer (D-OR), another Cannabis Caucus co-chair and longtime marijuana reform advocate, gave an impassioned speech in support of the bill.

“We’re not rushing to legalize marijuana,” he said. “The American people have all ready done that. We’re here because Congress has failed to deal with the disastrous war on drugs and do its part for the over 50 million regular marijuana users [who live in] every one of your districts.”

“It’s time for Congress to step up and do its part,” he said. “We need to catch up with the rest of the American people.”

Rep. Jim Jordan (R-OH) repeated the GOP criticism of Democratic priorities with this vote and slammed the tax provisions of the MORE Act.

“This bill—it’s not enough just to legalize marijuana. They want taxpayers to pay for it,” he said of Democrats. “This bill sets up a grant program. This is the marijuana business infrastructure bill.”

Prior to the vote on final passage, the House considered a motion to recommit—the minority party’s only tool to amend the bill—from Rep. Debbie Lesko (R-AZ) to add language clarifying that “an employer may test an employee or applicant for cannabis use to ensure workplace and public safety.” That proposal was rejected by a tally of 218 to 174, with one member voting present.

“In the middle of the COVID-19 pandemic House Democrats are rushing to pass a sweeping marijuana legalization bill without considering the unintended consequences the legislation will have on workplace and public safety,” she said. The vote on the motion will occur after the vote on passage.

“Wars are costly, and the war on marijuana is no exception,” Rep. David Cicilline (D-RI) said. “The costs of the war on marijuana have disproportionately fell on the backs of blacks and Latinos.”

Rep. Lou Correa (D-CA) noted that “than half of all Americans live in a state where cannabis is legal” and said Congress should “align federal cannabis laws with the will of the people. Let’s take full advantage of the medical benefits of cannabis.”

He also thanked House Judiciary Chairman Jerrold Nadler (D-NY), the bill’s sponsor, for including one of his proposals to require a study of the benefits of medical cannabis for veterans in an adopted manager’s amendment.

“For far too long, we have treated marijuana as a criminal justice problem instead of as a matter of personal choice and public health,” Nadler, who was not present for the debate, said in a written statement.

“Whatever one’s views are on the use of marijuana for recreational or medicinal use, the policy of arrests, prosecution, and incarceration at the Federal level has proven unwise and unjust,” he said.

“The bottom line is, this vote is about freedom,” Rep. Tulsi Gabbard (D-HI) said. “It’s about freedom of choice for every American to make their own decisions for themselves without fear of the government coming and arresting them.”

Rep. Andy Biggs (R-AZ) voiced opposition to the legislation and inaccurately claimed that voters in his state “barely” approved a measure to legalize marijuana during last month’s election. In fact, it passed 60-40 percent—a point Blumenauer later clarified.

The chairwoman of the House Small Business Committee, Rep. Nydia Velázquez (D-NY), said the bill “will restore justice to our most marginalized communities and it will boost our economy.” She added that “communities of color have disproportionately suffered from the so-called war on drugs” and they “have also been locked out of traditional capital markets.”

“That is why the MORE Act is the best legislation to advance progress on this issue,” she said.

It’s been about a year since the legislation cleared the Judiciary Committee. Advocates have been pushing for a floor vote ever since, and leadership initially said that would take place in September. But certain centrist Democrats urged a delay, citing concerns about the optics of advancing the reform before passing another round of coronavirus relief.

Leadership agreed but promised a floor vote before the year’s end. Majority Leader Steny Hoyer (D-MD) recently announced that the action would take place this week, and the procedural rules for floor consideration were approved in committee on Wednesday. The House began preliminary debate and accepted the rule—which closed the bill to further amendments—on Thursday.

GOP lawmakers have repeatedly hit House leadership after plans of the vote on the MORE Act were announced. While many have lashed out on Twitter, Senate Majority Leader Mitch McConnell (R-KY) took to the floor of his chamber to condemn the move on Thursday, sarcastically mocking Democrats for “spending this week on pressing issues like marijuana.”

One House Democrat, Rep. Conor Lamb (D-PA), echoed the GOP criticism, saying that this “isn’t the right way” to advance reform and arguing that lawmakers should instead be focused on COVID-19 relief.

Before coming to the floor, the legislation was revised in a Rules Committee Print, transmitted from Nadler’s Judiciary panel, and further modified in a manager’s amendment he filed. Most of the revisions were technical in nature, though there was one significant change as it relates to the proposed tax structure for marijuana.

As now structured, the MORE Act would make it so cannabis would be federally taxed at five percent for the first two years after implementation and then increased by one percent each year until reaching eight percent. After five years, taxes would be applied to marijuana products based on weight rather than price.

The bill would also create a pathway for resentencing for those incarcerated for marijuana offenses, as well as protect immigrants from being denied citizenship over cannabis and prevent federal agencies from denying public benefits or security clearances due to its use.

A new Cannabis Justice Office under the Justice Department would be responsible for distributing funds providing loans for small cannabis businesses owned and controlled by socially and economically disadvantaged individuals. The bill also seeks to minimize barriers to licensing and employment in the legal industry.

It would also establish a Community Reinvestment Grant Program. Tax dollars appropriated to that program would go to job training, legal aid for criminal and civil cases such as those concerning marijuana-related expungements, literacy programs and youth recreation and mentoring services, among other programs.

In new changes that some reform advocates take exception to, the legislation also stipulates that the heads of the Transportation Department and Coast Guard may continue to include marijuana in drug testing programs for safety-sensitive positions and clarifies that the expungement provisions only apply to “non-violent marijuana offenders” and bars so-called “kingpins” from obtaining expungements.

Advocates were optimistic about the bill’s advancement through the House, but it should be noted that its prospects in the GOP-controlled Senate this session are dim. McConnell is a champion of the hemp industry but staunchly opposes further marijuana reform.

Still, the historic nature of a vote by a chamber of Congress to legalize marijuana is hard to overstate. While the House has on two previous occasions approved amendments to shield all state marijuana laws from federal interference (which later died in the Senate), never before has legislation to formally remove cannabis from the Controlled Substances Act advanced on Capitol Hill.

Legalization advocates heralded the vote as a watershed moment for the movement.

Justin Stekal, political director of NORML, said this “is a historic day for marijuana policy in the United States.”

“This vote marks the first time in 50 years that a chamber of Congress has ever revisited the classification of cannabis as a federally controlled and prohibited substance, and it marks the first time in 24 years—when California became the first state defy the federal government on the issue of marijuana prohibition—that Congress has sought to close the widening chasm between state and federal marijuana policies,” he said. “By establishing this new trajectory for federal policy, we expect that more states will revisit and amend the archaic criminalization of cannabis, establish regulated consumer marketplaces, and direct law enforcement to cease the practice of arresting over half a million Americans annually for marijuana-related violations—arrests which disproportionately fall upon those on people of color and those on the lower end of the economic spectrum.”

Aaron Smith, chief executive officer of the National Cannabis Industry Association said that “the symbolic and historical importance of the MORE Act passing in the House cannot be overstated.”

“This vote stands as a rebuke of failed and harmful prohibition policies, and represents a growing understanding of their racially and economically disparate impacts,” he said. “Americans are increasingly ready to see cannabis legal for adults and sensibly regulated, which they showed through their representatives today and at the ballot box last month.”

Steve Fox, a strategic advisor to the Cannabis Trade Federation, said it is “a day of celebration for everyone who has worked to end cannabis prohibition over the past 25 years. All of those efforts have built toward this day.”

While celebrating the overall legislation, Marijuana Policy Project Executive Director Steve Hawkins noted that “it falls short of a perfect bill and at least one provision can hopefully be removed before final enactment.”

“An amendment inserted in the final days before today’s vote would empower the federal government to prevent Americans who have been charged with cannabis-related felonies from working in the marijuana industry,” he said. “This policy could block many of those individuals accused of prior marijuana offenses from participating in the legal market, which will inhibit our ability to create an equitable and fair marijuana industry. The fact that it might apply to people who were never even convicted of a crime makes it particularly unacceptable.”

Overall, the passage of the legalization legislation could send a strong signal to the incoming presidential administration, and it sets the stage for similar action in 2021—especially if Democrats win control of the Senate after two runoff elections in Georgia next month.

Given President-elect Joe Biden’s former approach to championing punitive anti-drug legislation as a senator and his ongoing obstinance on marijuana legalization at a time when polls show that a clear majority of Americans favor the policy change, there remains some skepticism about his willingness to make good on his campaign promises to achieve more modest reforms he has endorsed, such as decriminalizing possession and expunging records.

A transition document the incoming Biden-Harris administration released this month left out mention of those cannabis pledges. While Harris is sponsoring the MORE Act, she’s indicated that she would not necessarily push the president-elect to adopt a pro-legalization position.

That said, the president-elect has conceded that his work on punitive anti-drug legislation during his time in Congress was a “mistake.”

For his part, Blumenauer told Marijuana Moment in August that “the Biden administration and a Biden Department of Justice would be a constructive player” in advancing legalization.

Meanwhile, the Congressional Research Service released an analysis of the MORE Act last month, finding that the bill’s passage could “reverse” the current cannabis policy gap that exists between states and the federal government.

Featured image by Gina Coleman/Weedmaps


This article has been republished from Marijuana Moment under a content-sharing agreement. Read the original article here.

The post House approves federal cannabis legalization bill appeared first on Weedmaps News.

Read More
Call Now
Are you 21 or older? This website requires you to be 21 years of age or older. Please verify your age to view the content, or click "Exit" to leave.
Enable Notifications Yes, please keep me updated No thanks
Skip to toolbar